CD274 and neoplasm: Although GCs have a tumor-suppressive role, there have been recent clinical observations indicating that they may not be responsive to immune checkpoint inhibitors (such as anti-PD-L1), possibly due to their immunosuppressive effect resulting in inadequate tumor proliferation and growth [310].